References

In-text Citations

1. Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology. 2018;57(suppl_4):iv51–iv60.
2. Sakellariou G, Conaghan PG, Zhang W, Bijlsma JWJ, Boyesen P, D’Agostion MA, Dohert M, Fodor D, Kloppenburg M, Miese F, Naredo E, Porcheret M, Iagnocco A. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis. Ann Rheum Dis. 2017 Sep;76(9):1484-1494. doi: 10.1136/annrheumdis-2016-210815. Epub 2017 Apr 7.
3. Bowden JL, Hunter DJ, Deveza LA, Duong V, Dziedzic KS, Allen KD, et al. Core and adjunctive interventions for osteoarthritis: Efficacy and models for implementation. Nature Reviews Rheumatology. 2020;16(8):434-47.
4. Hart DA, Werle J, Robert J, Kania-Richmond A. Long wait times for knee and hip total joint replacement in Canada: An isolated health system problem, or a symptom of a larger problem? Osteoarthritis and Cartilage Open. 2021;3(2):100141.

In-text Citations

1. None

In-text Citations

1. de Zwart AH, Dekker J, Lems WF, Roorda LD, Van Der Esch M, Van Der Leeden M. Factors associated with upper leg muscle strength in knee osteoarthritis: A scoping review. Journal of rehabilitation medicine. 2018;50(2):140-50.
2. Øiestad BE, Juhl CB, Eitzen I, Thorlund JB. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis. Osteoarthritis and Cartilage. 2015;23(2):171-7.
3. Musumeci G, Aiello FC, Szychlinska MA, Di Rosa M, Castrogiovanni P, Mobasheri A. Osteoarthritis in the XXIst century: Risk factors and behaviours that influence disease onset and progression. International Journal of Molecular Sciences. 2015;16(3):6093-112.
4. Bowden JL, Hunter DJ, Deveza LA, Duong V, Dziedzic KS, Allen KD, et al. Core and adjunctive interventions for osteoarthritis: Efficacy and models for implementation. Nature Reviews Rheumatology. 2020;16(8):434-47.
5. Rice D, McNair P, Huysmans E, Letzen J, Finan P. Best evidence rehabilitation for chronic pain part 5: Osteoarthritis. Journal of Clinical Medicine. 2019;8(11):1769.
6. Holden MA, Button K, Collins NJ, Henrotin Y, Hinman RS, Larsen JB, et al. Guidance for implementing best practice therapeutic exercise for people with knee and hip osteoarthritis: what does the current evidence base tell us? Arthritis Care & Research. 2020;Accepted for publication.
7. Canadian Society for Exercise Physiology. Canadian 24-hour movement guidelines: An integration of physical activity, sedentary behavior, and sleep Ottawa, Ontario: Canadian Society for Exercise Physiology; 2021 [Available from: https://csepguidelines.ca/].
8. World Health Organization. WHO guidelines on physical activity and sedentary behavior. Geneva; 2020.

In-text Citations

1. Godziuk K, Kania-Richmond A, Hart D. Obesity: Implications for patients with osteoarthritis.
2. World Health Organization. Body mass index – BMI Copenhagen, Denmark: WHO Regional Office for Europe; 2021 [Available from: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.
3. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. International Journal of Obesity. 2009;33(3):289-95.
4. Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: A cross‐sectional study. Arthritis & Rheumatism. 2012;64(12):3947-54.
5. Jin WS, Choi EJ, Lee SY, Bae EJ, Lee T-H, Park J. Relationships among obesity, sarcopenia, and osteoarthritis in the elderly. Journal of Obesity & Metabolic Syndrome. 2017;26(1):36–44.
6. Godziuk K, Prado CM, Woodhouse LJ, Forhan M. The impact of sarcopenic obesity on knee and hip osteoarthritis: A scoping review. BMC Musculoskeletal Disorders. 2018;19(1):1-10.
7. Kahan S. Overweight and obesity management strategies. The American Journal of Managed Care. 2016;22(7):S186-S96.
8. Obesity Canada. Canadian Adult Obesity Clinical Practice Guidelines (CPGs) Edmonton, Alberta: Obesity Canada; 2020 [Available from: https://obesitycanada.ca/guidelines/chapters/.

In-text Citations

1. Bowden JL, Hunter DJ, Deveza LA, Duong V, Dziedzic KS, Allen KD, et al. Core and adjunctive interventions for osteoarthritis: Efficacy and models for implementation. Nature Reviews Rheumatology. 2020;16(8):434-47.
2. Gay C, Chabaud A, Guilley E, Coudeyre E. Educating patients about the benefits of physical activity and exercise for their hip and knee osteoarthritis. Systematic literature review. Annals of Physical and Rehabilitation Medicine. 2016;59(3):174-83.
3. Rice D, McNair P, Huysmans E, Letzen J, Finan P. Best evidence rehabilitation for chronic pain part 5: Osteoarthritis. Journal of Clinical Medicine. 2019;8(11):1769.
4. Wellsandt E, Golightly Y. Exercise in the management of knee and hip osteoarthritis. Current Opinion in Rheumatology. 2018;30(2):151-9.
5. Yu SP, Hunter DJ. Managing osteoarthritis. Australian Prescriber. 2015;38(4):115-9.
6. Ali SA, Walsh KE, Kloseck M. Patient perspectives on improving osteoarthritis management in urban and rural communities. Journal of pain research. 2018;11:417-25.
7. Bryk C, Lewis TR, Miller J, Penman C, Teare S. The Experience of Waiting for Help with Osteoarthritis. Calgary, AB: PACER; 2013. Contract No.: Report.
8. Ivers N, Dhalla IA, Allan GM. Opioids for osteoarthritis pain: Benefits and risks. Canadian Family Physician. 2012;58(12).
9. Toward Optimized Practice (TOP). PEER simplified guideline: Medical Cannabinoids clinical practice guideline. 2018.

In-text Citations

1. None

In-text Citations

1. None

1. American Academy of Orthopaedic Surgeons. Management of osteoarthritis of the hip evidence-based clinical practice guideline. Rosemont, Illinois; 2017. 
2. Ariani A, Manara M, Fioravanti A, Iannone F, F. S, Ughi N, et al. The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of knee, hip and hand osteoarthritis. Reumatismo. 2019;71(S1):5-21. 
3. Arthroscopy Association of Canada, Kopka M, Sheehan B, Degen R, Wong I, Hiemstra L, et al. Arthroscopy Association of Canada position statement on intra-articular injections for knee osteoarthritis. Orthopaedic Journal of Sports Medicine. 2019;7(7). 
4. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and cartilage. 2019;27(11):1578-89. 
5. Brosseau L, Taki J, Desjardins B, Thevenot O, Fransen M, Wells GA, et al. The Ottawa panel clinical practice guidelines for the management of knee osteoarthritis. Part one: introduction, and mind-body exercise programs. Clinical Rehabilitation. 2017;31(5):582-95. 
6. Bruyère O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Seminars in Arthritis and Rheumatism. 2019;49(3):337-50. 
7. Danish Health Authority. National clinical guideline on hip osteoarthritis: Non-surgical treatment and rehabilitation following total hip arthroplasty. 2016. 
8. Fernandes L, Hagen KB, Bijlsma JWJ, Andreassen O, Christensen P, Conaghan PG, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Annals of the rheumatic diseases. 2013;72(7):1125-35. 
9. Health Quality Ontario. Osteoarthritis: Care for adults with osteoarthritis of the knee, hip, or hand. Toronto, Ontario: Health Quality Ontario; 2018. 
10. Kear BM, Guck TP, McGaha AL. Timed Up and Go (TUG) Test: Normative Reference Values for Ages 20 to 59 Years and Relationships With Physical and Mental Health Risk Factors. J Prim Care Community Health. 2017;8(1):9-13. 
11. Kielly J, Davis EM, Marra C. Practice guidelines for pharmacists: The management of osteoarthritis. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2017;150(3):156-68. 
12. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis & Rheumatology. 2020;72(2):220-33. 
13. MacDonald KV, Sanmartin C, Langlois K, Marshall DA. Symptom onset, diagnosis and management of osteoarthritis. Health Rep. 2014;25(9):10-7.  
14. Marra CA, Cibere J, Tsuyuki RT, Soon JA, Esdaile JM, Gastonguay L, et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum. 2007;57(7):1238-44. 
15. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-88. 
16. National Institute for Health and Care Excellence (NICE) Osteoarthritis: Care and management. National Institute for Health and Care Excellence (NICE); 2014; last updated 11 December 2020. 
17. Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the US bone and joint initiative. Seminars in Arthritis and Rheumatism. 2014;43(6):701-12. 
18. Newberry SJ, FitzGerald J, SooHoo NF, Booth M, Marks J, Motala A, et al. Treatment of osteoarthritis of the knee: An update review. Rockville, Maryland: Agency for Healthcare Research and Quality (US); 2017. 
19. NSW Agency for Clinical Innovation. Musculoskeletal network: Osteoarthritis chronic care program model of care. Chatswood, NSW; 2012. 
20. Osthoff A-KR, Niedermann K, Braun J, Adams J, Brodin N, Dagfinrud H, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Annals of the rheumatic diseases. 2018;77:1251-60. 
21. Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis: Second edition. East Melbourne, Australia: Royal Australian College of General Practitioners; 2018. 
22. Royal Dutch Society for Physical Therapy. KNGF guideline: Osteoarthritis of the hip-knee. Royal Dutch Society for Physical Therapy; 2018. 
23. Sakellariou G, Conaghan PG, Zhang W, Bijlsma JWJ, Boyesen P, D’Agostino MA, et al. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis. Annals of the rheumatic diseases. 2017;76:1484-94.
24. Stoffer MA, Smolen JS, Woolf A, Ambrozic A, Berghea F, Boonen A, et al. Development of patient-centred standards of care for osteoarthritis in Europe: The eumusc. net-project. Annals of the rheumatic diseases. 2014;74(6):1145-9. 
25. The Scottish Government. Allied health professionals musculoskeletal pathway minimum standards. Edinburgh, Scotland: The Scottish Government; 2015. 
26. Ton J, Perry D, Thomas B, Allan GM, Lindblad AJ, McCormack J, et al. PEER umbrella systematic review of systematic reviews: Management of osteoarthritis in primary care. Canadian Family Physician. 2020;66(3).
27. Toward Optimized Practice (TOP). PEER simplified guideline: Medical Cannabinoids clinical practice guideline. 2018.